![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, June 27, 2014 10:55:56 PM
As has been mentioned here before, by me and others, there is going to be a drop off in volume as the mutual funds and ETFs matching the Russell indices taper off their buying. Although shares will be tightly held by longs, it is much easier to push around the stock price of a smaller company like NNVC with tightly held shares when there is lower volume. It may be a roller coaster ride.
I think the inclusion in the multiple Russell indexes will help stabilize the price a bit. If the general market (and small caps) goes up, there will be creation of units for ETFs and mutual funds which will buy NNVC stock and help NNVC go where the market goes (and vice versa).
But the milestones to come in the near term are delayed and less likely to act as a surprise upward catalyst on the share price.
As nice as it is to see a Certificate of Occupancy, it was not the Equipment and Process Validation nor the start of Regulatory Toxicity I was looking for. And I am beginning to worry that the company will wait for some product from the new facility to use to complete the Toxicity testing - and worse, maybe not start this round of Reg Toxicity testing until they have some of this material. (NOTE: the company never communicated this - it is my own speculation.)
That could potentially set back the timing at least 6-9 months for Tox and Clinicals. I really hope I am wrong on this point.
I am anticipating we have seen a short term top in the share price (knowing I could be wrong).
I have sold a fair bit of my shares in the hopes of buying back again later at a lower price.
I still see the company, the technology and the stock as a good long-term investment.
Recent NNVC News
- NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • InvestorsHub NewsWire • 05/02/2024 02:07:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/16/2024 09:53:32 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/14/2024 09:55:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/19/2024 09:44:48 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/04/2023 09:08:49 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 10/13/2023 08:30:41 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 09/28/2023 08:44:54 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/01/2023 08:46:45 PM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM